Microneedle-mediated drug delivery for Parkinson's disease: advances, challenges, and future perspectives
{{output}}
Parkinson's disease (PD) is the second most prevalent neurodegenerative disorder worldwide, affecting over 8.5 million individuals, with prevalence projected to exceed 12 million by 2040 due to global population aging. The escalating burden of PD presents sub... ...
